The effect of sericin on bone regeneration in a streptozotocin-induced type i diabetes animal model

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

There is an association between diabetes and impaired bone healing. The purpose of this study was to determine whether sericin had a positive effect on bone regeneration with streptozotocin-induced diabetes in a rat model. Sprague Dawley rats (n = 21) were assigned to one of three groups. A critical-sized bone defect was created on the calvaria. In the sericin group (S group, n = 7), the bone defect was filled with a sericin–gelatin combination, whereas in the gelatin group (G group, n = 7), only gelatin sponge was used. The control group (N group, n = 7) did not receive any graft. New bone formation was evaluated by micro-computerized tomogram and histological analysis. The regenerated bone volume in group S was the highest among the three groups (3.87 ± 2.51 mm3 ), followed by group N (1.71 ± 1.65 mm3 ) and group G (1.24 ± 1.05 mm3 ). The application of sericin in combination with a gelatin sponge enhanced the process of bone regeneration in streptozotocin-induced type I diabetes animal model.

Cite

CITATION STYLE

APA

Hong, K. D. G., Kang, Y. J., Oh, J. H., Kim, S. G., Park, Y. W., Jo, Y. Y., … Rotaru, H. (2021). The effect of sericin on bone regeneration in a streptozotocin-induced type i diabetes animal model. Applied Sciences (Switzerland), 11(4), 1–8. https://doi.org/10.3390/app11041369

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free